Keyphrases
Systematic Meta-analysis
100%
Meta-analysis
88%
COVID-19
48%
Patients with COVID-19
27%
Hydroxychloroquine
26%
Randomized Controlled Trial
21%
Peru
19%
COVID-19 Patients
19%
Confidence Interval
18%
Sepsis
15%
Meta-analysis of Randomized Controlled Trials
14%
PubMed
13%
AIDS/HIV
13%
Monkeypox
13%
Neonate
13%
Lipid Profile Levels
13%
Colchicine
13%
Mortality Prediction
13%
Atazanavir
13%
Efavirenz
13%
Mean Platelet Volume
13%
Risk of Bias
10%
Length of Hospital Stay
10%
Scopus
10%
Web of Science
10%
Hospitalized Patients
10%
Clinical Features
10%
Embase
9%
Inverse Variance
8%
Antibiotic Use
8%
Pregnant Women
8%
Risk Ratio
8%
Epidemiological Characteristics
8%
Random Effects Model
8%
Early Treatment
7%
Ecuador
7%
Platelets
7%
Hemoglobin
7%
Epidemiological Situation
7%
Mental Health
7%
Virus Infection
7%
Observational Research
7%
Hospitalized COVID-19 Patients
7%
Diagnostic Accuracy
7%
Adverse Events
6%
Drug Delivery Platform
6%
Disability
6%
Neutrophil-to-lymphocyte Ratio
6%
Post-acute
6%
COVID-19 Impact
6%
Medicine and Dentistry
Systematic Review
98%
Meta-Analysis
60%
COVID-19
57%
Monkeypox
26%
Infection
22%
Prevalence
20%
Cohort Analysis
20%
Disease
17%
Mixed Infection
13%
Atazanavir
13%
Efavirenz
13%
Dalteparin Sodium
13%
Apixaban
13%
Sepsis
10%
Prematurity
9%
Antibiotics
9%
Odds Ratio
9%
Human Immunodeficiency Virus
9%
Intensive Care Unit
9%
Abscess
8%
Malignant Neoplasm
8%
HIV/AIDS
7%
Health Survey
7%
Diagnostic Accuracy
7%
Virus DNA
7%
Depression
6%
Neutrophil
6%
Major Bleeding
6%
Venous Thromboembolism
6%
Human Leukocyte Antigen
6%
Reinfection
6%
Gingival Recession
6%
Resistant Hypertension
6%
Kidney Denervation
6%
Renal Artery
6%
Acute Graft Versus Host Disease
6%
Tiprelestat
6%
Antiviral Therapy
6%
Leishmania
6%
Docking (Molecular)
6%
Leishmania donovani
6%
Family Health
6%
Mean Platelet Volume
6%
Cat-Scratch Disease
6%
Staphylococcus Aureus
6%
Agents Acting on the Eye
6%
Neonate
6%
Severe Depression
6%
First Trimester Pregnancy
6%
Kidney Injury
6%
Pharmacology, Toxicology and Pharmaceutical Science
Monkeypox
43%
Disease
41%
Randomized Controlled Trial
31%
Infection
29%
Hydroxychloroquine
26%
Sepsis
23%
Coronavirinae
19%
Prevalence
17%
Cross-Sectional Study
16%
Adverse Event
15%
Observational Study
15%
Cohort Study
13%
Random Effects Model
13%
Colchicine
13%
Atazanavir
13%
Efavirenz
13%
Dalteparin
13%
Virus Infection
13%
Randomized Clinical Trial
13%
HIV
9%
Mixed Infection
8%
Antibiotic Agent
8%
Procalcitonin
8%
Monkeypox Virus
7%
Antivirus Agent
7%
Clinical Feature
7%
Antibiotics
6%
Endothelial Dysfunction
6%
Reinfection
6%
Hypernatremia
6%
Resistant Hypertension
6%
Chloroquine
6%
Myocarditis
6%
Lipoprotein
6%
Chemotherapy
6%
Leishmania donovani
6%
Mucocutaneous Lymph Node Syndrome
6%
Bacterial Infection
6%
Bleeding
6%
Venous Thromboembolism
6%
Diabetes Mellitus
6%
Apixaban
6%
Staphylococcus Aureus
6%
Malignant Neoplasm
6%
Triple Negative Breast Cancer
6%
Hyperglycemia
6%
Heart Infarction
6%
Newborn Sepsis
6%
Kidney Injury
6%
Hypercholesterolemia
6%
